Literature DB >> 2462013

Recombinant vaccinia/Venezuelan equine encephalitis (VEE) virus expresses VEE structural proteins.

R M Kinney1, J J Esposito, B J Johnson, J T Roehrig, J H Mathews, A D Barrett, D W Trent.   

Abstract

cDNA molecules encoding the structural proteins of the virulent Trinidad donkey and the TC-83 vaccine strains of Venezuelan equine encephalitis (VEE) virus were inserted under control of the vaccinia virus 7.5K promoter into the thymidine kinase gene of vaccinia virus. Synthesis of the capsid protein and glycoproteins E2 and E1 of VEE virus was demonstrated by immunoblotting of lysates of CV-1 cells infected with recombinant vaccinia/VEE viruses. VEE glycoproteins were detected in recombinant virus-infected cells by fluorescent antibody (FA) analysis performed with a panel of VEE-specific monoclonal antibodies. Seven E2-specific epitopes and two of four E1-specific epitopes were demonstrated by FA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2462013     DOI: 10.1099/0022-1317-69-12-3005

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Localization of four antigenic sites involved in Venezuelan equine encephalomyelitis virus protection.

Authors:  E V Agapov; I A Razumov; I V Frolov; A A Kolykhalov; S V Netesov; V B Loktev
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

2.  Treatment of mice with human monoclonal antibody 24h after lethal aerosol challenge with virulent Venezuelan equine encephalitis virus prevents disease but not infection.

Authors:  Ann R Hunt; Richard A Bowen; Shana Frederickson; Toshiaki Maruyama; John T Roehrig; Carol D Blair
Journal:  Virology       Date:  2011-04-13       Impact factor: 3.616

Review 3.  Vaccinia virus vectors: new strategies for producing recombinant vaccines.

Authors:  D E Hruby
Journal:  Clin Microbiol Rev       Date:  1990-04       Impact factor: 26.132

4.  Expression of processed core protein of hepatitis C virus in mammalian cells.

Authors:  S Harada; Y Watanabe; K Takeuchi; T Suzuki; T Katayama; Y Takebe; I Saito; T Miyamura
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

5.  Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein.

Authors:  R M Kinney; G J Chang; K R Tsuchiya; J M Sneider; J T Roehrig; T M Woodward; D W Trent
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

6.  Comparative analysis of the alphavirus-based vectors expressing Rift Valley fever virus glycoproteins.

Authors:  Rodion Gorchakov; Eugenia Volkova; Nadezda Yun; Olga Petrakova; Nathaniel Seth Linde; Slobodan Paessler; Elena Frolova; Ilya Frolov
Journal:  Virology       Date:  2007-05-16       Impact factor: 3.616

7.  A novel MVA vectored Chikungunya virus vaccine elicits protective immunity in mice.

Authors:  James Weger-Lucarelli; Haiyan Chu; Matthew T Aliota; Charalambos D Partidos; Jorge E Osorio
Journal:  PLoS Negl Trop Dis       Date:  2014-07-24

8.  Therapeutic monoclonal antibody treatment protects nonhuman primates from severe Venezuelan equine encephalitis virus disease after aerosol exposure.

Authors:  Crystal W Burke; Jeffery W Froude; Franco Rossi; Charles E White; Crystal L Moyer; Jane Ennis; M Louise Pitt; Stephen Streatfield; R Mark Jones; Konstantin Musiychuk; Jukka Kervinen; Larry Zeitlin; Vidadi Yusibov; Pamela J Glass
Journal:  PLoS Pathog       Date:  2019-12-02       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.